Lv4
800 积分 2021-11-03 加入
钠-葡萄糖共转运蛋白2抑制剂在2型糖尿病患者中的临床应用获益及潜在风险
1个月前
已完结
中国药物性肝损伤诊治指南（2023年版）
1个月前
已完结
中文版8条目Morisky服药依从性量表在2型糖尿病患者中的信效度评价及应用研究
1个月前
已关闭
Comorbidity Burden and Health Services Use in Community-Living Older Adults with Diabetes Mellitus: A Retrospective Cohort Study
1个月前
已完结
The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24-month analysis of time to first significant treatment change, treatment persistence and clinical outcomes
1个月前
已关闭
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline Characteristics
1个月前
已完结
Comparison of medication persistence and adherence in type 2 diabetes using a once-weekly regimen of DPP-4 inhibitor compared with once-daily and twice-daily regimens: a retrospective cohort study of Japanese health insurance claims data
1个月前
已完结
Effectiveness, safety, and tolerability of vildagliptin or vildagliptin/metformin combination in patients with type 2 diabetes uncontrolled on insulin therapy in a real-world setting in Egypt: The OMEGA study
2个月前
已完结
Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study
2个月前
已完结
Current insights and emerging trends in early-onset type 2 diabetes
2个月前
已完结
皖公网安备34019202002308
